Abd El-moneam, A., Ebrahim, A., Mustafa, A., Abd-Halim, W. (2022). Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata. Benha Journal of Applied Sciences, 7(10), 25-32. doi: 10.21608/bjas.2022.284644
A.A. Abd El-moneam; A.A. Ebrahim; A.I. Mustafa; W.A. Abd-Halim. "Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata". Benha Journal of Applied Sciences, 7, 10, 2022, 25-32. doi: 10.21608/bjas.2022.284644
Abd El-moneam, A., Ebrahim, A., Mustafa, A., Abd-Halim, W. (2022). 'Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata', Benha Journal of Applied Sciences, 7(10), pp. 25-32. doi: 10.21608/bjas.2022.284644
Abd El-moneam, A., Ebrahim, A., Mustafa, A., Abd-Halim, W. Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata. Benha Journal of Applied Sciences, 2022; 7(10): 25-32. doi: 10.21608/bjas.2022.284644
Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata
Dermatology Venereology and Andrology Dept., Faculty of Medicine, Benha Univ., Benha, Egypt
Abstract
Alopecia areata is an autoimmune disease characterized by non-scarring hair loss in single or multiple areas of the scalp, face or body. Human beta-defensin 1 is a protein that in humans is encoded by the DEFB1 gene. Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Human beta defensin 1 was purified from hemodialysate fluid, but its tissue sources were not identified. Aim:To evaluate serum level of human beta defensin 1 to reveal its role in alopecia areata pathogenesis and to relate with studied clinical parameters. Patients and methods: This prospective casecontrol study was included fourty patients with AA (Group A) and fourty age and sex matched apparently healthy subjects as a control group (Group B). Patients were selected from the Dermatology outpatient clinic of Benha University Hospitals in the period between December 2018 and June 2019. Results:we found that AA group showed no significant difference in serum level of HBD-1 when compared to control group (p=0.03). HBD-1 concentration was not considered as predictor of AA.Conclusion: HBD-1 concentration was not considered as a predictor of AA susceptibility and severity.